Cerebrospinal fluid analysis

作者: Gavin Giovannoni

DOI: 10.1016/B978-0-444-52001-2.00029-7

关键词: Multiple sclerosisBlood–brain barrierMyelin basic proteinPathologyNeural cell adhesion moleculeContext (language use)AntigenCerebrospinal fluidMedicineGlial fibrillary acidic proteinImmunology

摘要: The cerebrospinal fluid (CSF) is a bodily fluid, which both easily accessible and the most proximate to pathological alterations of multiple sclerosis (MS). Consequently, analysis this provides an important window into underpinnings disease. For example, for years, it has been known that CSF MS patients contains oligoclonal gamma immunoglobulins (IgG), are synthesized within central nervous system presumably relate immune dysfunction, characteristically found in MS. This insight lead introduction highly-effective anti-B-cell therapies field therapeutics. Moreover, presence IgG response CSF, although not specific MS, very sensitive finding and, as result, its can be quite helpful establishing diagnosis right clinical context. In addition, predictive value. Thus, without definite who have bands significantly more likely develop compared those such banding pattern. Other biological molecules also including neurofiliment, myelin basic protein (MBP), glial fibrillary acidic (GFAP), tau, neuronal cell adhesion molecule (NCAM), growth associated (GAP-43). However, value measuring these (and other) constituents diagnostic prognostic purposes following therapy still determined.

参考文章(171)
Martin Valis, Pavel Stourac, Jiri Masopust, Ctirad Andrys, Radomir Talab, Tau protein, phosphorylated tau protein and beta-amyloid42 in the cerebrospinal fluid of multiple sclerosis patients. Neuro endocrinology letters. ,vol. 29, pp. 971- 976 ,(2008)
Frank J. Flier, Pieter F. De Vries Robbé, Nosology and Causal Necessity; The Relation BetweenDefining a Disease and Discovering its Necessary Cause Theoretical Medicine and Bioethics. ,vol. 20, pp. 577- 588 ,(1999) , 10.1023/A:1009994603779
H. F. Petereit, W. Moeller-Hartmann, D. Reske, A. Rubbert, Rituximab in a patient with multiple sclerosis--effect on B cells, plasma cells and intrathecal IgG synthesis. Acta Neurologica Scandinavica. ,vol. 117, pp. 399- 403 ,(2007) , 10.1111/J.1600-0404.2007.00958.X
K. Blennow, P. Fredman, A. Wallin, C.G. Gottfries, H. Frey, T. Pirttilä, I. Skoog, C. Wikkelsö, L. Svennerholm, Formulas for the quantitation of intrathecal IgG production. Their validity in the presence of blood-brain barrier damage and their utility in multiple sclerosis. Journal of the Neurological Sciences. ,vol. 121, pp. 90- 96 ,(1994) , 10.1016/0022-510X(94)90161-9
K. Felgenhauer, H.-J. Schädlich, M. Nekic, R. Ackermann, Cerebrospinal fluid virus antibodies Journal of the Neurological Sciences. ,vol. 71, pp. 291- 299 ,(1985) , 10.1016/0022-510X(85)90067-X
Patricia Morris, Nicholas W.S. Davies, Geoffrey Keir, A screening assay to detect antigen-specific antibodies within cerebrospinal fluid. Journal of Immunological Methods. ,vol. 311, pp. 81- 86 ,(2006) , 10.1016/J.JIM.2006.01.015
D. Franciotta, E. Zardini, F. Lolli, G. Giovannoni, G. Davies, G. Keir, E. Thompson, The clinical significance of an intrathecal monoclonal immunoglobulin band A follow-up study Neurology. ,vol. 62, pp. 1163- 1166 ,(2004) , 10.1212/WNL.62.4.675